Fig. 3From: Integration of clinical and transcriptomics reveals programming of the lipid metabolism in gastric cancerValidation the lipidomics signature in validation cohort. (A) Patient survival status and time distributed by lipid-score for each validation cohort; (B) the distribution of lipid score for each validation cohort; (C) K -M survival curve of the lipid-score for the OS time of each validation cohort. The dotted line indicates the individual inflection point of the risk score curve, by which the patients were categorized into low- and high-risk groupsBack to article page